 Jenna Guthmiller
Concepts (164)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hemagglutinin Glycoproteins, Influenza Virus | 12 | 2025 | 25 | 4.040 |
Why?
| | Influenza Vaccines | 16 | 2025 | 539 | 3.950 |
Why?
| | Antibodies, Viral | 18 | 2025 | 625 | 3.460 |
Why?
| | B-Lymphocytes | 11 | 2025 | 847 | 3.130 |
Why?
| | Orthomyxoviridae | 6 | 2022 | 40 | 3.060 |
Why?
| | Influenza, Human | 13 | 2025 | 622 | 2.840 |
Why?
| | Immunity, Humoral | 14 | 2024 | 116 | 2.540 |
Why?
| | Immunologic Memory | 8 | 2025 | 353 | 2.020 |
Why?
| | Orthomyxoviridae Infections | 5 | 2024 | 67 | 1.850 |
Why?
| | Influenza A Virus, H1N1 Subtype | 5 | 2025 | 148 | 1.810 |
Why?
| | Malaria | 8 | 2021 | 63 | 1.670 |
Why?
| | Antigens | 3 | 2024 | 357 | 1.520 |
Why?
| | Epitopes | 8 | 2025 | 479 | 1.510 |
Why?
| | Antibodies, Neutralizing | 10 | 2025 | 286 | 1.450 |
Why?
| | Epitopes, B-Lymphocyte | 3 | 2025 | 17 | 1.290 |
Why?
| | Antibody Formation | 6 | 2024 | 298 | 1.240 |
Why?
| | Germinal Center | 3 | 2020 | 58 | 1.190 |
Why?
| | Antigens, Viral | 5 | 2022 | 178 | 1.080 |
Why?
| | Influenza A Virus, H5N1 Subtype | 1 | 2024 | 8 | 0.930 |
Why?
| | Polysaccharides | 2 | 2024 | 79 | 0.920 |
Why?
| | Receptors, Virus | 1 | 2024 | 83 | 0.900 |
Why?
| | Spike Glycoprotein, Coronavirus | 3 | 2021 | 109 | 0.850 |
Why?
| | Vaccination | 7 | 2025 | 1381 | 0.810 |
Why?
| | Antibodies, Monoclonal | 6 | 2023 | 1430 | 0.760 |
Why?
| | Amino Sugars | 1 | 2021 | 6 | 0.730 |
Why?
| | Interleukin-10 | 3 | 2021 | 302 | 0.730 |
Why?
| | Eggs | 1 | 2021 | 25 | 0.720 |
Why?
| | Host-Pathogen Interactions | 2 | 2021 | 364 | 0.710 |
Why?
| | Influenza A virus | 1 | 2021 | 107 | 0.670 |
Why?
| | Coronavirus | 1 | 2020 | 47 | 0.660 |
Why?
| | Receptors, Antigen, T-Cell | 2 | 2023 | 718 | 0.630 |
Why?
| | Plasma Cells | 4 | 2021 | 71 | 0.630 |
Why?
| | Protein Engineering | 2 | 2024 | 97 | 0.620 |
Why?
| | Antibodies, Protozoan | 3 | 2021 | 36 | 0.610 |
Why?
| | Immunity, Innate | 1 | 2024 | 828 | 0.570 |
Why?
| | Mutation | 2 | 2024 | 3958 | 0.510 |
Why?
| | Malaria Vaccines | 1 | 2015 | 8 | 0.460 |
Why?
| | Receptors, Antigen, B-Cell | 3 | 2025 | 130 | 0.450 |
Why?
| | Molecular Biology | 1 | 2015 | 59 | 0.450 |
Why?
| | Antibody Affinity | 4 | 2024 | 60 | 0.440 |
Why?
| | Cross Reactions | 4 | 2021 | 133 | 0.430 |
Why?
| | Immunoglobulin Fab Fragments | 2 | 2024 | 59 | 0.420 |
Why?
| | Antibody Specificity | 2 | 2025 | 189 | 0.400 |
Why?
| | Animals | 20 | 2025 | 36940 | 0.390 |
Why?
| | Lymphocyte Activation | 4 | 2021 | 1142 | 0.390 |
Why?
| | Plasmodium | 3 | 2017 | 13 | 0.370 |
Why?
| | Humans | 33 | 2025 | 137585 | 0.360 |
Why?
| | Plasmodium yoelii | 3 | 2021 | 5 | 0.360 |
Why?
| | Hemagglutinins | 2 | 2021 | 9 | 0.340 |
Why?
| | Adjuvants, Immunologic | 2 | 2024 | 226 | 0.340 |
Why?
| | Plasmodium falciparum | 2 | 2020 | 30 | 0.300 |
Why?
| | Flow Cytometry | 3 | 2024 | 1178 | 0.280 |
Why?
| | CD4-Positive T-Lymphocytes | 3 | 2021 | 1091 | 0.270 |
Why?
| | Antimalarials | 3 | 2021 | 31 | 0.260 |
Why?
| | Cryoelectron Microscopy | 2 | 2024 | 190 | 0.250 |
Why?
| | Virology | 1 | 2025 | 24 | 0.230 |
Why?
| | Sialic Acids | 1 | 2024 | 10 | 0.230 |
Why?
| | Societies, Scientific | 1 | 2025 | 51 | 0.230 |
Why?
| | Complementarity Determining Regions | 2 | 2024 | 51 | 0.230 |
Why?
| | Cattle Diseases | 1 | 2024 | 24 | 0.230 |
Why?
| | Mice | 11 | 2022 | 17787 | 0.220 |
Why?
| | High-Throughput Screening Assays | 1 | 2025 | 158 | 0.210 |
Why?
| | Single-Cell Analysis | 2 | 2024 | 313 | 0.210 |
Why?
| | High-Throughput Nucleotide Sequencing | 2 | 2024 | 539 | 0.200 |
Why?
| | Molecular Dynamics Simulation | 1 | 2024 | 213 | 0.200 |
Why?
| | Cell Separation | 1 | 2024 | 318 | 0.200 |
Why?
| | Immunoglobulin A | 2 | 2021 | 211 | 0.190 |
Why?
| | Cattle | 1 | 2024 | 984 | 0.190 |
Why?
| | Immune System | 1 | 2023 | 177 | 0.190 |
Why?
| | DNA, Protozoan | 2 | 2020 | 32 | 0.180 |
Why?
| | Binding Sites | 1 | 2024 | 1303 | 0.180 |
Why?
| | Immunodominant Epitopes | 1 | 2021 | 27 | 0.180 |
Why?
| | Disease Resistance | 1 | 2021 | 34 | 0.180 |
Why?
| | Influenza A Virus, H3N2 Subtype | 1 | 2021 | 45 | 0.180 |
Why?
| | Protein Binding | 2 | 2024 | 2224 | 0.180 |
Why?
| | Phosphatidylserines | 1 | 2021 | 91 | 0.170 |
Why?
| | Genes, Immunoglobulin | 1 | 2020 | 28 | 0.170 |
Why?
| | Chickens | 1 | 2021 | 191 | 0.170 |
Why?
| | Immunoglobulin Fc Fragments | 1 | 2021 | 41 | 0.170 |
Why?
| | Somatic Hypermutation, Immunoglobulin | 1 | 2020 | 19 | 0.170 |
Why?
| | Cell Differentiation | 2 | 2021 | 1991 | 0.170 |
Why?
| | Mice, Inbred C57BL | 7 | 2021 | 5757 | 0.170 |
Why?
| | CD8-Positive T-Lymphocytes | 2 | 2018 | 900 | 0.160 |
Why?
| | Hemolysis | 1 | 2021 | 206 | 0.160 |
Why?
| | Symptom Assessment | 1 | 2020 | 128 | 0.160 |
Why?
| | Receptors, OX40 | 2 | 2017 | 15 | 0.150 |
Why?
| | T-Lymphocytes, Helper-Inducer | 2 | 2021 | 137 | 0.150 |
Why?
| | Protein Domains | 1 | 2020 | 289 | 0.150 |
Why?
| | Immunoglobulin Light Chains | 1 | 2019 | 47 | 0.150 |
Why?
| | Immunity | 1 | 2019 | 143 | 0.150 |
Why?
| | Immunoglobulin Heavy Chains | 1 | 2019 | 83 | 0.150 |
Why?
| | Immunity, Heterologous | 1 | 2018 | 2 | 0.150 |
Why?
| | Antigenic Variation | 1 | 2018 | 10 | 0.150 |
Why?
| | HEK293 Cells | 1 | 2021 | 730 | 0.150 |
Why?
| | Vaccines, Attenuated | 2 | 2019 | 132 | 0.150 |
Why?
| | Phosphoproteins | 1 | 2021 | 338 | 0.150 |
Why?
| | Female | 13 | 2024 | 73304 | 0.140 |
Why?
| | Seasons | 1 | 2020 | 547 | 0.140 |
Why?
| | Anemia, Hemolytic, Autoimmune | 1 | 2017 | 14 | 0.140 |
Why?
| | Toll-Like Receptor 9 | 1 | 2017 | 32 | 0.140 |
Why?
| | Malaria, Falciparum | 1 | 2017 | 27 | 0.140 |
Why?
| | Immunophenotyping | 1 | 2019 | 318 | 0.140 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2016 | 852 | 0.140 |
Why?
| | Autoimmunity | 1 | 2023 | 908 | 0.140 |
Why?
| | B-Lymphocyte Subsets | 1 | 2017 | 75 | 0.130 |
Why?
| | Th1 Cells | 1 | 2017 | 143 | 0.130 |
Why?
| | Erythrocytes | 3 | 2021 | 700 | 0.130 |
Why?
| | Polymerase Chain Reaction | 1 | 2019 | 1062 | 0.120 |
Why?
| | Interferon Type I | 1 | 2016 | 140 | 0.120 |
Why?
| | Cell Line | 1 | 2021 | 2847 | 0.120 |
Why?
| | Software | 1 | 2020 | 665 | 0.120 |
Why?
| | Male | 11 | 2022 | 67762 | 0.110 |
Why?
| | T-Lymphocyte Subsets | 1 | 2016 | 417 | 0.110 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2016 | 385 | 0.100 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2015 | 249 | 0.100 |
Why?
| | Mice, Knockout | 2 | 2017 | 3015 | 0.100 |
Why?
| | Disease Models, Animal | 3 | 2020 | 4295 | 0.100 |
Why?
| | T-Lymphocytes | 1 | 2021 | 1996 | 0.100 |
Why?
| | Transcription, Genetic | 1 | 2018 | 1457 | 0.090 |
Why?
| | Adult | 8 | 2021 | 37929 | 0.090 |
Why?
| | Neutralization Tests | 2 | 2021 | 75 | 0.090 |
Why?
| | Gastrointestinal Microbiome | 1 | 2019 | 697 | 0.090 |
Why?
| | Anti-Bacterial Agents | 1 | 2019 | 1809 | 0.080 |
Why?
| | Healthy Volunteers | 2 | 2019 | 199 | 0.080 |
Why?
| | Biomarkers | 1 | 2019 | 4149 | 0.070 |
Why?
| | Middle Aged | 4 | 2021 | 33479 | 0.070 |
Why?
| | Computational Biology | 2 | 2021 | 644 | 0.060 |
Why?
| | Immunoglobulin G | 2 | 2020 | 893 | 0.060 |
Why?
| | Awards and Prizes | 1 | 2025 | 67 | 0.050 |
Why?
| | Australia | 1 | 2025 | 315 | 0.050 |
Why?
| | Neuraminidase | 1 | 2022 | 24 | 0.050 |
Why?
| | Convalescence | 1 | 2021 | 17 | 0.050 |
Why?
| | Cells, Cultured | 2 | 2021 | 4193 | 0.050 |
Why?
| | Binding Sites, Antibody | 1 | 2021 | 42 | 0.040 |
Why?
| | Epitope Mapping | 1 | 2021 | 62 | 0.040 |
Why?
| | Chick Embryo | 1 | 2021 | 130 | 0.040 |
Why?
| | Immunization, Passive | 1 | 2020 | 90 | 0.040 |
Why?
| | Proof of Concept Study | 1 | 2020 | 78 | 0.040 |
Why?
| | Plasma | 1 | 2021 | 212 | 0.040 |
Why?
| | Immunogenicity, Vaccine | 1 | 2019 | 30 | 0.040 |
Why?
| | Vaccines, Inactivated | 1 | 2019 | 68 | 0.040 |
Why?
| | Host-Parasite Interactions | 1 | 2020 | 114 | 0.040 |
Why?
| | Galectins | 1 | 2018 | 24 | 0.040 |
Why?
| | N-Acetylglucosaminyltransferases | 1 | 2018 | 22 | 0.040 |
Why?
| | Lymphocytic choriomeningitis virus | 1 | 2018 | 29 | 0.040 |
Why?
| | Receptors, Interferon | 1 | 2017 | 52 | 0.030 |
Why?
| | Glycosylation | 1 | 2018 | 151 | 0.030 |
Why?
| | T-Box Domain Proteins | 1 | 2017 | 98 | 0.030 |
Why?
| | Amino Acid Sequence | 1 | 2020 | 2139 | 0.030 |
Why?
| | Amino Acids | 1 | 2020 | 497 | 0.030 |
Why?
| | Neutrophils | 1 | 2021 | 1238 | 0.030 |
Why?
| | Mice, Transgenic | 1 | 2020 | 2167 | 0.030 |
Why?
| | Transcriptome | 1 | 2021 | 971 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2021 | 1774 | 0.030 |
Why?
| | Young Adult | 2 | 2020 | 13209 | 0.030 |
Why?
| | Pandemics | 1 | 2021 | 1639 | 0.020 |
Why?
| | Cytokines | 1 | 2021 | 2085 | 0.020 |
Why?
| | Adolescent | 2 | 2020 | 21513 | 0.020 |
Why?
| | Autoantibodies | 1 | 2017 | 1496 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2020 | 10811 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2015 | 2607 | 0.020 |
Why?
| | Signal Transduction | 1 | 2018 | 5079 | 0.010 |
Why?
| | United States | 1 | 2020 | 14841 | 0.010 |
Why?
| | Aged | 1 | 2020 | 23961 | 0.010 |
Why?
|
|
Guthmiller's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|